Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Headquarters:
Oxford, Oxfordshire, United Kingdom
Last Funding Date:
2021-12-16
Total Funding:
35017490
Last Funding Type:
Series B
Number Of Exists:
11-50
Founded Date:
2010-01-01
Investors Number:
6
Industry:
Aging Biomarkers
Employee Number:
9
Estimated Revenue:
$33.16M
Funding Status:
Early Stage Venture